Hey guys, if you missed it, Doximity ($DOCS) agreed to a **$31M settlement** with investors over claims that the company masked declining sales.
Quick recap: On April 1, 2024, Jehosaphat Research released a report raising concerns about Doximity’s healthcare advertising business. After the report came out, **$DOCS fell, wiping** out more than **$135M in shareholder value over two days**.
Now, the good news is that the company agreed to settle **$31M** with them, and even though the deadline has passed recently, they’re accepting late claims.
If you held $DOCS between **2021 and 2023**, you can still check the details and see if you may be eligible [here](https://11th.com/cases/doximity-investor-suit).
